4 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Cellceutix Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis Prurisol, Placebo - Plaque Psoriasis | Phase 2 | Completed | Cellceutix Corporation | 115 | 2015-08-01 | 2017-07-19 |
| Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers Prurisol, Ziagen - Psoriasis | Phase 1 | Completed | Cellceutix Corporation | 18 | 2014-03-01 | 2018-10-26 |
| Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections Daptomycin, Brilacidin - Skin Infection, Bacterial Infection | Phase 2 | Completed | Cellceutix Corporation | 215 | 2014-02-01 | 2018-09-26 |
| A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors thioureidobutyronitrile - Solid Tumors | Phase 1 | Completed | Cellceutix Corporation | 48 | 2012-10-01 | 2016-02-24 |
Psoriasis (2) · Abscess (1) · Bacterial Infections (1) · Carcinoma (1) · Cellulitis (1) · Erysipelas (1) · Neoplasms (1) · Skin Diseases (1) · Spinocerebellar Ataxias (1) · Staphylococcal Infections (1) · Wound Infection (1)
abacavir hydroxyacetate (2) · Daptomycin (1) · Tablets (1) · abacavir (1) · brilacidin (1)
United States (4)
Geoffrey Shapiro, MD PhD (1) · Krishna Menon (1) · William O'Riordan, MD (1)